In This Issue:

- Summary

- Case Analysis

- Implications

..Prokaryotic Nucleic Acid Sequences

..Short Segments of Eukaryotic DNA

..Promoters/Regulatory regions

..Isolated Proteins

..Antibodies

..Mutations

..Regulatory RNA sequences

..Genetically modified organisms

- Suggestions

..Issued Patents

..New or Presently Pending Applications

- For More Information

- Excerpt from Summary:

On Thursday, June 13, 2013, the Supreme Court held that a patent claim directed to “an isolated DNA molecule” was not patent eligible under 35 U.S.C. §101 solely because the DNA molecule had been “isolated” from the rest of the genome. The Court found, however, that a cDNA (complementary DNA) molecule may be patent eligible, because a cDNA molecule is “not found in nature.” This conclusion assumes that a cDNA molecule is different from the genomic sequence because it lacks intron sequences.